Sarcomatoid renal cancer with multiple cutaneous metastases
DOI:
https://doi.org/10.48193/revistamexicanadeurologa.v80i5.543Keywords:
renal cell carcinoma, sarcomatoid, metastasis, sarcomatoid factor, prognosisAbstract
Clinical case description: A 47-year-old man presented with violet-red nodular cutaneous lesions on the face, scalp, and hands. Biopsy report stated metastatic kidney tumor. Physical examination revealed fair general status and a palpable abdominal mass. Urinalysis showed microhematuria. Tomography identified a right kidney tumor infiltrating the perirenal fat. Right radical nephrectomy was performed, and the histopathologic study described a clear cell renal cell tumor, with a 60% sarcomatoid component. Sunitinib was begun, resulting in cutaneous lesion involution. During two weeks of intermittent therapy, the lesions reappeared, and the dose was modified. Three months later, the patient presented with brain, liver, and bone metastases. After showing no improvement, the patient died five months after diagnosis.
Relevance: Not only was our case one of a rare form of metastatic kidney cancer that recurred despite treatment with tyrosine kinase therapy, the tumor also had sarcomatoid differentiation, a very aggressive variant of kidney cancer.
Clinical implications: Cutaneous metastases from kidney cancer have an incidence of approximately 3%. Even though their prognosis is not good, opportune detection is essential for the patient.
Conclusions: Sarcomatoid renal cancer is a rare tumor with a poor prognosis and is generally associated with distant metastasis. Every patient diagnosed with kidney cancer should undergo a comprehensive skin assessment, for adequate staging and treatment.
References
Zhang L, Wu B, Zha Z, Zhao H, Feng Y. The prognostic value and clinicopathological features of sarcomatoid differentiation in patients with renal cell carcinoma: a systematic review and meta-analysis. Cancer Manag Res. 2018;10:1687-703. DOI: https://dx.doi.org/10.2147%2FCMAR.S166710
Kyriakopoulos CE, Chittoria N, Choueiri TK, Kroeger N, Lee JL, Srinivas S, et al. Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Clin Genitourin Cancer. 2015;13(2):e79-85. DOI: https://doi.org/10.1016/j.clgc.2014.08.011
Yang HJ, Kang SY. Cutaneous metastatic renal cell carcinoma to the scalp. Arch Craniofac Surg. 2019;20(6):392-6. DOI: https://doi.org/10.7181/acfs.2019.00206
Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernandez-Pello S, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. Eur Urol. 2019;75(5):799-810. DOI: https://doi.org/10.1016/j.eururo.2019.02.011
Zhang H, Majeed NK, Sharifi R, Guzman G. A Case of Sarcomatoid Renal Cell Carcinoma With Osseous Metaplasia and Papillary Renal Cell Carcinoma Metastasis. Clin Pathol. 2019;12:2632010X19848005. DOI: https://doi.org/10.1177/2632010X19848005
Comperat E, Varinot J. Classification of Adult Renal Tumors: An Update. Semin Ultrasound CT MR. 2017;38(1):2-9. DOI: https://doi.org/10.1053/j.sult.2016.08.004
Lopez-Beltran A, Carrasco JC, Cheng L, Scarpelli M, Kirkali Z, Montironi R. 2009 update on the classification of renal epithelial tumors in adults. Int J Urol. 2009;16(5):432-43. DOI: https://doi.org/10.1111/j.1442-2042.2009.02302.x
Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. Eur Urol. 2016;70(1):106-19. DOI: https://doi.org/10.1016/j.eururo.2016.02.028
Farrow GM, Harrison EG, Jr., Utz DC, ReMine WH. Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. I. Cancer. 1968;22(3):545-50. DOI: https://doi.org/10.1002/1097-0142(196809)22:3<545::AID-CNCR2820220308>3.0.CO;2-4
Vélez DM, Gual JB, Gravalos RG-M, Rodríguez IM. Carcinoma renal sarcomatoide localizado.¿ Qué factores pueden prever su evolución? Actas Urológicas Españolas. 2002;26(1):60-5. DOI: https://doi.org/10.1016/S0210-4806(02)72732-0
Kim T, Zargar-Shoshtari K, Dhillon J, Lin HY, Yue B, Fishman M, et al. Using percentage of sarcomatoid differentiation as a prognostic factor in renal cell carcinoma. Clin Genitourin Cancer. 2015;13(3):225-30. DOI: https://doi.org/10.1016/j.clgc.2014.12.001
Kunene V, Miscoria M, Pirrie S, Islam MR, Afshar M, Porfiri E. Sarcomatoid renal cell carcinoma: clinical outcome and survival after treatment with sunitinib. Clin Genitourin Cancer. 2014;12(4):251-5. DOI: https://doi.org/10.1016/j.clgc.2013.12.001
Achkar T, Arjunan A, Wang H, Saul M, Davar D, Appleman LJ, et al. High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid features. PLoS One. 2017;12(12):e0190084. DOI: https://doi.org/10.1371/journal.pone.0190084
Glockner JF, White LM, Sundaram M, McDonald DJ. Unsuspected metastases presenting as solitary soft tissue lesions: a fourteen-year review. Skeletal Radiol. 2000;29(5):270-4. DOI: https://doi.org/10.1007/s002560050606
Nibhoria S, Tiwana KK, Kaur M, Kumar S. A clinicopathological and immunohistochemical correlation in cutaneous metastases from internal malignancies: a five-year study. J Skin Cancer. 2014;2014:793937. DOI: https://doi.org/10.1155/2014/793937
Fernandez-Rueda P, Ruiz-Lopez P, Ramirez-Negrin MA, Fuentes-Suarez A, Toussaint-Caire S, Vega-Memije ME. [Cutaneous metastasis of renal cell carcinoma: A case report and review of the literature]. Gac Med Mex. 2015;151(4):533-7.
Paolino G, Lido P, Bei R, Polisca P. Undifferentiated metastatic renal cell carcinoma presenting as a cutaneous nodular lesion. Turk J Urol. 2015;41(4):228-30. DOI: https://doi.org/10.5152/tud.2015.53254
Amin A, Burgess EF. Skin manifestations associated with kidney cancer. Semin Oncol. 2016;43(3):408-12. DOI: https://doi.org/10.1053/j.seminoncol.2016.02.016
Ohlsson R, Geertsen L, Berge Stuveseth S, Lund L. Cutaneous metastases in renal cell carcinoma: a systematic review and a case report. Scand J Urol. 2019;53(1):9-13. DOI: https://doi.org/10.1080/21681805.2019.1585473
Koga S, Tsuda S, Nishikido M, Matsuya F, Saito Y, Kanetake H. Renal cell carcinoma metastatic to the skin. Anticancer Res. 2000;20(3B):1939-40.
Logunova V, Sokumbi O, Iczkowski KA. Metastatic sarcomatoid renal cell carcinoma manifesting as a subcutaneous soft tissue mass. J Cutan Pathol. 2017;44(10):874-7. DOI: https://doi.org/10.1111/cup.12998
Walton J, Li J, Clifton MM, Mori RL, Park AM, Sumfest JM. Metastatic clear cell renal cell carcinoma to the forearm without identifiable primary renal mass. Urol Case Rep. 2019;27:100989. DOI: https://doi.org/10.1016/j.eucr.2019.100989
Kostopoulos N, Platsidaki E, Tzanetakou V, Petraki K, Lekarakou M, Bafaloukos D, et al. Nodular Lesions on the Upper Trunk: An Uncommon Anatomical Site of Renal Tumor Metastases. Indian J Dermatol. 2019;64(3):251. DOI: https://doi.org/10.4103/ijd.ijd_634_16
Kesireddy M, Correa A, Correa R, Venkatesan R. A Pedunculated Skin Lesion in a Case of Clear Cell Renal Carcinoma. Cureus. 2019;11(6):e5021. DOI: https://doi.org/10.7759/cureus.5021
Cui P, Cong X, Yin J, Liu M, Wang X, Yang L, et al. Metastases to the nose from clear cell renal cell carcinoma: A case report. Medicine (Baltimore). 2019;98(4):e14012. DOI: https://doi.org/10.1097/md.0000000000014012
Basic-Jukic N, Mesar I, Kirincich J. Cutaneous Metastasis as a Presenting Feature of Renal Adenocarcinoma in a Renal Transplant Recipient: A Case Report. Transplant Proc. 2019;51(9):3072-3. DOI: https://doi.org/10.1016/j.transproceed.2019.04.021
Georgy JT, Mathuram AJ, George AA, Chandramohan J. Renal cell carcinoma presenting as a cutaneous horn and nodules on the gingiva and scalp. BMJ Case Rep. 2017;2017. DOI: http://dx.doi.org/10.1136/bcr-2017-220913
Gradecki SE, Gru AA. An unusual case of sarcomatoid renal cell carcinoma presenting in the skin by direct extension at a laparoscopic port site. J Cutan Pathol. 2020;47(7):617-20. DOI: https://doi.org/10.1111/cup.13657
Raychaudhuri R, Riese MJ, Bylow K, Burfeind J, Mackinnon AC, Tolat PP, et al. Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm. Clin Genitourin Cancer. 2017;15(5):e897-e901. DOI: https://doi.org/10.1016/j.clgc.2017.05.018
Maiti A, Nemati-Shafaee M, Msaouel P, Pagliaro LC, Jonasch E, Tannir NM, et al. Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma. Clin Genitourin Cancer. 2017. DOI: https://doi.org/10.1016/j.clgc.2017.07.028
Park I, Cho YM, Lee JL, Ahn JH, Lee DH, Song C, et al. Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component. J Cancer Res Clin Oncol. 2013;139(5):817-27. DOI: http://dx.doi.org/10.1007/s00432-013-1386-4.
Shuch B, Bratslavsky G, Linehan WM, Srinivasan R. Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist. 2012;17(1):46-54. DOI: https://doi.org/10.1634/theoncologist.2011-0227
Karashima T, Fukuhara H, Tamura K, Ashida S, Kamada M, Inoue K, et al. Expression of angiogenesis-related gene profiles and development of resistance to tyrosine-kinase inhibitor in advanced renal cell carcinoma: characterization of sorafenib-resistant cells derived from a cutaneous metastasis. Int J Urol. 2013;20(9):923-30. DOI: https://doi.org/10.1111/iju.12084
Hammers HJ, Verheul HM, Salumbides B, Sharma R, Rudek M, Jaspers J, et al. Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study. Mol Cancer Ther. 2010;9(6):1525-35 DOI: https://doi.org/10.1158/1535-7163.mct-09-1106
